Skip to content

Prospective cohort study on reperfusion therapy for STEMI patients

Prospective cohort study on reperfusion therapy for STEMI patients

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096213
Enrollment
Unknown
Registered
2025-01-20
Start date
2024-10-09
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI

Interventions

Sponsors

The 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years old; (2) Diagnosed as STEMI: The diagnostic criteria for STEMI are: (1) a history of chest pain/discomfort; (2) At admission, if the ST segment of two or more adjacent electrocardiogram (ECG) leads is continuously elevated by = 0.1mV (>30min, V2 and V3 >= 0.2mV) or if there is a newly developed left bundle branch block (LBBB); (3) Elevated cardiac biomarkers [troponin, creatine kinase isoenzyme (CK-MB)] beyond the 99th laboratory reference limit percentile. (3) Sign a written informed consent form.

Exclusion criteria

Exclusion criteria: (1) STEMI is caused by surgical procedures, trauma, and gastrointestinal bleeding; (2) STEMI occurs in patients who have already been hospitalized for other reasons; (3) Researchers have determined that patients have poor compliance and are unable to complete the study as required; (4) Patient life expectancy <= 12 months; (5) Heart transplant patients.

Design outcomes

Primary

MeasureTime frame
1-year all-cause death;30 day stroke (including hemorrhagic and ischemic), cardiogenic shock, congestive heart failure, and The incidence of myocardial infarction;;1-year stroke (including hemorrhagic and ischemic), cardiogenic shock, congestive heart failure, and heart failure The incidence of myocardial infarction.;

Secondary

MeasureTime frame
Total ischemic time before reperfusion (including thrombolysis and PCI);Total reperfusion rate within the time window;The proportion of ECG regression (STR) = 70% after thrombolysis or emergency PCI surgery;TIMI blood flow grade 3 ratio before emergency PCI surgery;Post emergency PCI TIMI blood flow grade 3 ratio;30 day all-cause death and cardiac death;1-year cardiac death;

Countries

China

Contacts

Public ContactTao Chen

The 2nd Affiliated Hospital of Harbin Medical University

chentao198733@163.com+86 152 0460 7125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026